Surya Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 20.28 Cr
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 4,828.13 Cr
- Satisfied Charges ₹ 1,682.69 Cr
About Surya Pharmaceutical
Company Details
-
Location
North Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
L24232DL1992PLC227186
-
Company No.
227186
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
25 Mar 1992
-
Date of AGM
29 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Listed
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Surya Pharmaceutical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Goyal
|
Managing Director | 25-Mar-1992 | Current |
|
Bharat Jain
|
Company Secretary | 16-Jun-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Alka Goyal
|
Whole-Time Director | 24-Aug-1996 | Current |
|
Jasvinder Singh
|
Additional Director | 10-Oct-2013 | Current |
Financial Performance of Surya Pharmaceutical.
Enhance accessibility to Surya Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Pharmaceutical?
Unlock access to Surya Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Valuesource Mercantile LimitedRajiv Goyal and Alka Goyal are mutual person
-
Emm Bee Fincap Private Limited
Rajiv Goyal and Alka Goyal are mutual person
-
Medi Mart India Private Limited
Rajiv Goyal and Alka Goyal are mutual person
Charges (Loans)
₹4,828.13 Cr
₹1,682.69 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 3548.64 Cr
- Edelweiss Asset Reconstruction Company Limited : 435.50 Cr
- Punjab National Bank : 145.99 Cr
- Bank Of Baroda : 125.00 Cr
- Allahabad Bank : 115.00 Cr
- Others : 458.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2013 | State Bank Of India | ₹546.44 Cr | Open |
| 31 Dec 2012 | Punjab National Bank | ₹135.99 Cr | Open |
| 14 Feb 2012 | Idbi Bank Limited | ₹60.00 Cr | Open |
| 05 Jan 2012 | Punjab National Bank | ₹5.00 Cr | Open |
| 02 Nov 2011 | Punjab National Bank | ₹5.00 Cr | Open |
How Many Employees Work at Surya Pharmaceutical?
Surya Pharmaceutical has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
